跳至主要内容
临床试验/NCT07295210
NCT07295210已完成不适用

Boric Acid Versus 10% Povidone Iodine Solution in Treatment of Otomycosis: a Randomized Clinical Trial

Mansoura University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
objective clinical response

研究概览

简要总结

This study compares two topical agents for the treatment of fungal infection of the external auditory canal: boric acid and a 10% povidone-iodine solution

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • all consecutive patients with otomycosis, recruited from the outpatient clinic during the study duration

排除标准

  • tympanic membrane perforation
  • previous ear surgery
  • significant medical co-morbidities such as poorly controlled diabetes or immunocompromised patients
  • patient refusal to participate in the study

研究组 & 干预措施

Boric acid group

Active Comparator

干预措施: Boric acid (Drug)

Povidone iodine group

Active Comparator

干预措施: Povidone iodine 10% (Drug)

结局指标

主要结局

objective clinical response

时间窗: Days 7, 14, and 28 after treatment

clinical response is assessed by ear examination by presence or absence of fungal hyphae inside the external auditory canal

Microbiological response

时间窗: day 28 after treatment

Microbiological response is evaluated by obtaining cultures from the external auditory canal searching for fungal growth

次要结局

  • subjective pain response(days 7, 14, and 28 after treatment)
  • subjective itching response(days 7, 14, and 28 after treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Boric Acid Versus 10% Povidone Iodine Solution in... | 临床试验